Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

2.860 -0.360 (-11.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Savara Inc.
Via Business Wire
Why Shares of Savara Soared This Week
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases. 
Via The Motley Fool
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Savara Announces New Leadership Appointments
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
$1.2 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones edged lower on the first trading session of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Savara Announces New Employment Inducement Grant
From Savara Inc.
Via Business Wire
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Participate in Three Upcoming Investor Conferences
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara Presented Data at the European Respiratory Society (ERS) International Congress 2022
From Savara Inc.
Via Business Wire
Savara to Present at H.C. Wainwright 24th Annual Global Investment Conference
From Savara Inc.
Via Business Wire
Savara Announces Resignation of Chief Medical Officer
From Savara Inc.
Via Business Wire
Savara Awarded Promising Innovative Medicine (PIM) Designation in the United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
From Savara Inc.
Via Business Wire
Recap: Savara Q2 Earnings
  Savara (NASDAQ:SVRA) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara reported in-line EPS of... 
Via Benzinga
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces Acceptance of Three Abstracts at the European Respiratory Society (ERS) International Congress 2022
From Savara Inc.
Via Business Wire
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers 
Via Benzinga
Savara to Present at Jefferies Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at H.C. Wainwright Global Investment Conference
From Savara Inc.
Via Business Wire
Savara: Q1 Earnings Insights
Savara (NASDAQ:SVRA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Savara beat estimated earnings by... 
Via Benzinga
Savara Reports First Quarter 2022 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Savara Announces Debt Refinancing of $26.5M Credit Facility With Silicon Valley Bank
From Savara Inc.
Via Business Wire
Savara Reports Fourth Quarter / Year-End 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback